FDA Fails To Consider Risks Of Over The Counter Plan B

Main Category: Sexual Health / STDs
Also Included In: Regulatory Affairs / Drug Approvals;  Women's Health / Gynecology;  Pharmacy / Pharmacist
Article Date: 24 Apr 2009 - 5:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:3 stars

2.6 (5 votes)

Healthcare Prof:2 stars

1.8 (5 votes)


Moira Gaul, Family Research Council's Director of Women's and Reproductive Health, released the following statement regarding the Obama Administration's decision to sell the morning-after-pill to 17-year-olds without a prescription.

"The Obama Administration is permitting a judge to make a scientific decision as to the safety of the over-the-counter sale of Plan B. This decision places policy preferences before safety. The best interest of women's health is not advanced by these decisions. Reason, science, and compassion clearly are not the animating factors of the decision.

"In order for a drug to be sold over-the-counter, patients must be able to safely medicate themselves without medical supervision. Studies tracking the label comprehension for Plan B show poor awareness that Plan B is not a substitute for standard contraceptives. The FDA-approved label for Plan B gives no clear indication that repeated use of Plan B in a short period of time is not safe.

"FDA officials understood these safety concerns in 2006 and were not convinced that the label comprehension data for teens demonstrated that they could use Plan B safely. The FDA officials believed more data needed to be submitted.

"There is a real danger that Plan B may be given to women, especially sexually abused women and minors, under coercion or without their consent. Interaction with medical professionals is a major screening and defense mechanism for victims of sexual abuse. The availability of Plan B over-the-counter also bypasses the necessary routine medical care of sexually active girls and women, which is important for the screening of health conditions, and for providing screening for sexually transmitted diseases."

Source: Family Research Council

Article adapted by Medical News Today from original press release.
Visit our sexual health / stds section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Family Research Council. "FDA Fails To Consider Risks Of Over The Counter Plan B." Medical News Today. MediLexicon, Intl., 24 Apr. 2009. Web.
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/147364.php>

APA
Family Research Council. (2009, April 24). "FDA Fails To Consider Risks Of Over The Counter Plan B." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/147364.php.

Please note: If no author information is provided, the source is cited instead.


Sexual Health / STDs

Most Popular Articles



Follow Our Sexual Health News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Sexual Health / STDs Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »